Request Dataset
Contact us
Sign in
Lookup
HS API
Service Map
Crosswalk
Validation
Products
Prior Authorization
Businesses
Data Library
CMS Forms
Home
Healthcare Lookup Services
HCPCS Codes Lookup
M0222 | Similar
HCPCS Codes Similar to M0222
HCPCS Codes Similar to “M0222” Code.
Intravenous injection, bebtelovimab, includes injection and post administration monitoring
M0223
Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Code added date
: 20220211
Code effective date
: 20241213
TXT
|
PDF
|
XML
|
JSON
Q0222
Injection, bebtelovimab, 175 mg
Code added date
: 20220211
Code effective date
: 20241213
TXT
|
PDF
|
XML
|
JSON
M0224
Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring
Code added date
: 20240322
Code effective date
: 20240322
TXT
|
PDF
|
XML
|
JSON
M0235
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
M0236
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose
Code added date
: 20251001
Code effective date
: 20251001
TXT
|
PDF
|
XML
|
JSON
M0237
Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Code added date
: 20250124
Code effective date
: 20250124
TXT
|
PDF
|
XML
|
JSON
M0238
Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Code added date
: 20250124
Code effective date
: 20250124
TXT
|
PDF
|
XML
|
JSON
M0239
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring
Code added date
: 20201109
Code effective date
: 20210417
TXT
|
PDF
|
XML
|
JSON
M0240
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
Code added date
: 20210730
Code effective date
: 20241213
TXT
|
PDF
|
XML
|
JSON
M0241
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
Code added date
: 20210730
Code effective date
: 20241213
TXT
|
PDF
|
XML
|
JSON
M0243
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring
Code added date
: 20201121
Code effective date
: 20241213
TXT
|
PDF
|
XML
|
JSON
M0244
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Code added date
: 20210506
Code effective date
: 20241213
TXT
|
PDF
|
XML
|
JSON
M0245
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring
Code added date
: 20210209
Code effective date
: 20231214
TXT
|
PDF
|
XML
|
JSON
M0246
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency
Code added date
: 20210506
Code effective date
: 20231214
TXT
|
PDF
|
XML
|
JSON